Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis

Abstract

RKIP does not influence the tumorigenic properties of human prostate cancer cells. It appears to be a novel and clinically relevant suppressor of metastasis that may function by decreasing vascular invasion.